LONDON, April 10, 2014 /PRNewswire/ --
On Wednesday, April 09, 2014, the
US markets saw a positive sentiment, as the NASDAQ Composite closed
at 4,183.90, up 1.72%, the Dow Jones Industrial Average ended the
session at 16,437.18, up 1.11%, and the S&P 500 edged 1.09%
higher to finish the trading session at 1,872.18. The session saw a
positive impact from Information Technology, Health Care and
Materials sectors along with a drag from Utilities and
Telecommunication Services sectors. A number of stocks saw large
movements, including Athlon Energy Inc. (NYSE: ATHL), Venaxis Inc.
(NASDAQ: APPY), Desarrolladora Homex S.A.B. de C.V. (NYSE: HXM) and
ImmunoGen Inc. (NASDAQ: IMGN). Free technical research on ATHL,
APPY, HXM and IMGN can be downloaded upon signing up at:
http://www.investor-edge.com/1018-register
Shares in Athlon Energy Inc. finished Wednesday's session at
$37.94, up 13.12%, recording a new
52-week high of $38.94. A total of
2.22 million shares traded which is above its three months average
volume of 0.67 million shares. The stock vacillated between
$34.16 and $38.94 during the session.
The stock advanced 3.15% in the last one month, 35.94% in the
previous three months, and 25.42% on YTD basis. The S&P 500
Energy Sector Index mapped a gain of 0.48% during the trading
session and charted up 2.95% in the last one month. Additionally,
the stock has a Relative Strength Index (RSI) of 39.14 and is
trading above its 50-day moving average of $34.54. On April
08, the company announced that it has entered into multiple
definitive agreements with five unrelated third-party sellers to
acquire certain producing properties and undeveloped acreage for an
aggregate purchase price of $873
million in cash. Sign up today to read free research on ATHL
at:
http://www.investor-edge.com/1018-ATHL-10Apr2014.pdf
On Wednesday, Venaxis Inc.'s stock ended the day at $2.24, which is 10.34% higher than the previous
day's closing price of $2.03. A total
of 1.58 million shares were traded as compared to its three months
average volume of 0.76 million shares. During the session, the
stock oscillated between $2.07 and
$2.32. Shares of Venaxis Inc. have
gained 3.23% in the previous three trading sessions and 4.67% on
YTD basis, while the same has lost 14.99% in the last one month.
The S&P 500 Health Care Sector Index mapped a gain of 2.11%
during the trading session, while the same has declined 2.01% in
the last one month. Further, the stock has an RSI of 31.61 and is
trading above its 200-day moving average of $1.97. Sign up today to read free research on
APPY at:
http://www.investor-edge.com/1018-APPY-10Apr2014.pdf
Shares in Desarrolladora Homex S.A.B. de C.V. edged 10.71% higher,
finishing Wednesday's session at $1.55. A total of 0.80 million shares were traded
as compared with its three months average volume of 0.71 million
shares. The stock fluctuated between $1.42
and $1.63 during the trading session. Shares in
Desarrolladora Homex S.A.B. de C.V. have rallied 13.97% in the last
one month, 40.91% in the previous three months, and 32.48% on YTD
basis. The S&P 500 Consumer Discretionary Sector Index mapped a
gain of 1.08% during the trading session, while the same has
declined 3.84% in the last one month. Furthermore, the stock has an
RSI of 47.03 and is trading below its 50-day and 200-day moving
averages of $1.62 and $1.82, respectively. Sign up today to read free
research on HXM at:
http://www.investor-edge.com/1018-HXM-10Apr2014.pdf
ImmunoGen Inc.'s shares closed Wednesday's session at $14.74, up 6.50% with a trading volume of 1.11
million shares as compared with its three months average volume of
0.83 million shares. The stock traded between $13.87 and $14.84 during the session and has gone
up 0.48% on YTD basis. Shares in ImmunoGen Inc. have surged 10.91%
in the previous three trading sessions, while the same has fallen
by 7.64% in the last one month. The S&P 500 Health Care Sector
Index mapped a gain of 2.11% during the trading session and 2.86%
in the previous three months. Moreover, the stock has an RSI of
37.46 and is trading below its 50-day and 200-day moving averages
of $15.65 and $16.18, respectively. Sign up today to read free
research on IMGN at:
http://www.investor-edge.com/1018-IMGN-10Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge